Progenity (PROG) has priced its
IPO of ~6.7M common shares at $15.00 per share. Underwriters’
over-allotment is an additional 1.0M shares. Closing date is June 23.
Trading on the Nasdaq Global Market commences today.
The San Diego, CA-based molecular testing services provider’s lineup consists
of a non-invasive prenatal test for fetal chromosomal disorders, an
expanded carrier screen (preconception or early in pregnancy) for
genetic diseases, a hereditary cancer screen, a prenatal test for
monogenic disease and a portfolio of anatomic and molecular pathology
tests.
https://seekingalpha.com/news/3584525-progenity-prices-ipo-15-trading-kicks-off-today
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.